Stockscreener 앱 받기
1.57
4.27%
-0.07
시간 외 거래:
1.57
전일 마감가:
$1.64
열려 있는:
$1.6
하루 거래량:
764.74K
Relative Volume:
0.15
시가총액:
$115.43M
수익:
-
순이익/손실:
$-22.83M
주가수익비율:
-1.9873
EPS:
-0.79
순현금흐름:
$-20.87M
1주 성능:
-1.26%
1개월 성능:
+1.29%
6개월 성능:
+252.18%
1년 성능:
+230.94%
1일 변동 폭
$1.5501
$1.63
1주일 범위
$1.53
$1.83
52주 변동 폭
$0.2223
$3.83
Cognition Therapeutics Inc Stock (CGTX) Company Profile
명칭
Cognition Therapeutics Inc
전화
412-481-2210
주소
2403 SIDNEY STREET, PITTSBURGH
CGTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CGTX
Cognition Therapeutics Inc
|
1.57 | 144.69M | 0 | -22.83M | -20.87M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cognition Therapeutics Inc Stock (CGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-19 | 업그레이드 | B. Riley Securities | Neutral → Buy |
| 2024-07-30 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-11-03 | 개시 | B. Riley Securities | Buy |
| 2021-11-03 | 개시 | Oppenheimer | Outperform |
Cognition Therapeutics Inc 주식(CGTX)의 최신 뉴스
Will Cognition Therapeutics Inc. stock maintain momentum in 2025Analyst Upgrade & Weekly High Conviction Ideas - newser.com
Will Cognition Therapeutics Inc. stock benefit from upcoming earnings reportsVolume Spike & Risk Managed Trade Strategies - newser.com
How to use a screener to detect Cognition Therapeutics Inc. breakoutsDay Trade & Technical Pattern Based Signals - newser.com
What analyst consensus says on Cognition Therapeutics Inc. stockGlobal Markets & High Win Rate Trade Alerts - newser.com
Published on: 2025-11-04 02:40:25 - newser.com
Using Python tools to backtest Cognition Therapeutics Inc. strategiesWeekly Risk Report & Community Consensus Picks - newser.com
Why Cognition Therapeutics Inc. stock is a value investor pickMarket Risk Analysis & High Accuracy Swing Entry Alerts - newser.com
Will Cognition Therapeutics Inc. stock pay special dividendsWeekly Trade Review & Detailed Earnings Play Alerts - newser.com
Strategies to average down on Cognition Therapeutics Inc.Earnings Overview Summary & Weekly Sector Rotation Insights - newser.com
Why Cognition Therapeutics Inc. stock appeals to dividend seekersMarket Performance Summary & Accurate Intraday Trading Signals - newser.com
Will Cognition Therapeutics Inc. stock benefit from commodity pricesJuly 2025 Catalysts & Reliable Price Action Trade Plans - newser.com
Using AI based signals to follow Cognition Therapeutics Inc.July 2025 Patterns & Community Consensus Trade Alerts - newser.com
Why Cognition Therapeutics Inc. stock is a must watch in 2025July 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
Will earnings trigger a reversal in Cognition Therapeutics Inc.Weekly Profit Analysis & Weekly High Momentum Picks - newser.com
Analyzing Cognition Therapeutics Inc. with multi timeframe chartsGold Moves & AI Driven Stock Movement Reports - newser.com
Cognition Therapeutics Inc. stock volume spike explained2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Relative strength of Cognition Therapeutics Inc. in sector analysis2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - newser.com
3,670,187 Stock Options of Cognition Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 2-NOV-2025. - MarketScreener
2,541,781 Restricted Stock Units of Cognition Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 2-NOV-2025. - MarketScreener
Published on: 2025-10-31 05:52:59 - newser.com
Published on: 2025-10-31 04:16:22 - newser.com
What drives Cognition Therapeutics Inc stock priceResistance Breakout Alerts & Fast Growing Investment Ideas - earlytimes.in
Cognition Therapeutics (NASDAQ:CGTX) Stock Price Down 0.6%What's Next? - MarketBeat
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Cognition Therapeutics Inc (CGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):